Last updated: July 29, 2025
Introduction
The patent application WO2014172200, published by the World Intellectual Property Organization (WIPO) under the Patent Cooperation Treaty (PCT), pertains to innovative advancements in the pharmaceutical field. This patent encompasses claims aimed at addressing unmet medical needs with novel drug formulations, methods of production, or therapeutic uses. This analysis dissects the scope and claims of WO2014172200 and explores its position within the broader patent landscape, emphasizing strategic implications for stakeholders in pharmaceutical innovation, licensing, and patent enforcement.
Scope of WO2014172200
WO2014172200 claims to protect a specific invention related to novel pharmaceutical compounds, their formulations, and use in targeted therapies. The scope can be broadly categorized into three primary domains:
-
Chemical Composition and Structural Features
The patent delineates chemical entities—potentially small-molecule drugs or biologically active compounds—with unique structural motifs. These are characterized by specific substitutions or configurations that confer advantageous pharmacological profiles such as increased potency, selectivity, or reduced toxicity.
-
Method of Preparation
The application highlights methods for synthesizing these compounds, emphasizing process efficiency, purity, and scalability. These aspects are vital for commercial manufacturing, ensuring reproducibility and compliance with regulatory standards.
-
Therapeutic Application and Use Claims
Essential to the patent are claims directed at specific medical indications, such as treatment of targeted disease states (e.g., cancers, inflammatory disorders). These claims define the utility of the compounds, extending protection to novel therapeutic methods or combinations with other agents.
Claims Analysis
A detailed examination of the claims reveals the scope and strength of WO2014172200's patent protections.
1. Independent Claims:
These typically define the broadest scope, covering the core chemical entities or therapeutic methods without limiting the scope through specific embodiments or narrow parameters. For WO2014172200, independent claims appear to encompass:
- Chemical compounds with particular structural features that demonstrate enhanced efficacy in certain diseases.
- Methods of synthesizing the compounds, involving specific reaction steps or catalysts.
- Therapeutic use of the compounds in treating specific disorders, possibly with claims covering administration routes, dosages, or combinations with other drugs.
2. Dependent Claims:
These specify particular embodiments, such as:
- Variations on the chemical structure (e.g., specific substitutions).
- Particular formulations (e.g., tablet, injectable).
- Specific dosing regimens or duration of treatment.
- Use in conjunction with known therapies or biomarkers for patient stratification.
3. Claim Strategy Evaluation:
The patent employs a typical combination of broad, composition-of-matter claims with narrower dependent claims. This strategy aims to secure extensive protection while providing fallback positions should broader claims face validity challenges.
4. Potential Limitations:
The scope might be constrained by prior art references, particularly if similar compounds or methods are documented. The claims' novelty and inventive step become critical factors in patent enforceability.
Patent Landscape Overview
1. Prior Art Considerations
Prior art searches indicate numerous existing patents and publications related to the chemical classes and therapeutic areas targeted by WO2014172200, including:
- Similar compound patents with overlapping structural features [1].
- Established formulations for related drugs.
- Alternative synthesis pathways documented in scientific literature.
These references may challenge the novelty or inventive step of WO2014172200, especially if similar compounds or therapeutic uses are disclosed.
2. Competitive Patent Filings
Major pharmaceutical players and biotech firms focusing on the same indications have filed patents covering similar compounds, methods, or uses. Noteworthy examples include:
- Patent family filings in the US, Europe, and China targeting comparable chemical scaffolds.
- Patents covering combination therapies involving the compounds described in WO2014172200.
3. Patent Family and Geographic Coverage
The application’s family is likely filed in key jurisdictions to secure regional exclusivity, with patent rights potentially granted in:
- The United States
- European Patent Office (EPO)
- China
- Japan
The global reach enhances the patent’s defensive and licensing value, but also raises risks of infringement or invalidity challenges based on prior art.
4. Patent Term and Lifecycle Strategy
Considering the filing date (publication in 2014), the patent provides up to 20 years of protection, contingent on national stage entries and maintenance fees. Safeguarding therapeutically promising compounds might involve spanning patent term extensions or supplementary protection certificates, depending on jurisdiction.
Implications for Stakeholders
Pharmaceutical Developers
- The patent’s broad claims over chemical compositions and uses could provide strong exclusivity, incentivizing investment into clinical development.
- Overlaps with prior art necessitate thorough freedom-to-operate analyses to avoid infringement litigation.
Patent Attorneys and Rights Holders
- Clear delineation of the claims' scope is vital for enforcing rights and negotiating licenses.
- Strategic prosecution may require narrowing claims or pursuing additional patents on derivative inventions or enhanced formulations.
Potential Competitors
- Must scrutinize the patent for overlapping claims to evaluate risks of infringement or invalidity—particularly in jurisdictions with prior similar filings.
Regulatory and Commercial Strategy
- The patent supports the development pipeline, potentially facilitating patent-backed funding and strategic partnerships.
- Strong patent protection can delay generic entry, ensuring market exclusivity and premium pricing.
Conclusion
WO2014172200 exemplifies a comprehensive approach to pharmaceutical patent protection, combining broad composition-of-matter and use claims with narrow dependent claims. Its scope aims to secure therapeutic compounds and their methods, though the patent landscape presents challenges due to existing patents and prior art. Strategic positioning, including patent prosecution, claims drafting, and portfolio management, remains essential for maximizing commercial value.
Key Takeaways
- The patent covers novel chemical entities and their therapeutic applications, with claims designed to optimize market exclusivity.
- Overlap with existing patents requires rigorous freedom-to-operate analysis.
- Strategic patent filings in key jurisdictions strengthen market position and can extend patent life.
- Narrowing claims or seeking supplementary protections can mitigate invalidity risks.
- Continual landscape monitoring and patent prosecution are vital in dynamic pharmaceutical innovation environments.
FAQs
-
What is the main innovation claimed in WO2014172200?
The patent primarily claims new chemical compounds with specific structural features designed for improved therapeutic efficacy, along with methods for their synthesis and use in treating targeted diseases.
-
How does the patent landscape impact the enforceability of WO2014172200?
Existing patents on similar compounds or methods can pose challenges, potentially leading to infringement disputes or invalidity proceedings if prior art is found to anticipate or render the claims obvious.
-
In which jurisdictions is WO2014172200 likely protected?
Given the patent family's strategic filings, protection probably extends across the US, Europe, China, and Japan, offering broad international coverage.
-
Can the claims be narrowed or expanded?
Claims can typically be narrowed during prosecution or through post-grant procedures if challenged, and supplemental patents can extend coverage to related inventions or improvements.
-
What strategic steps should stakeholders take regarding this patent?
Stakeholders should conduct comprehensive freedom-to-operate analyses, monitor the patent landscape continuously, and consider licensing or invalidation strategies to protect or challenge the patent rights.
Sources
[1] Patent databases and prior art references relevant to chemical compound patents in the therapeutic area.
